InvestorsHub Logo
Followers 1
Posts 87
Boards Moderated 0
Alias Born 10/06/2017

Re: None

Wednesday, 02/24/2021 6:52:10 PM

Wednesday, February 24, 2021 6:52:10 PM

Post# of 233195
Put yourself in companies shoes. If you hit your primary endpoint you PR the news to the world. This also puts additional pressure on the FDA. If you miss it but there are pockets of data that possibly support EUA....You send the unblinded data and hope the agencies clear a path to market for you. Like i said. Im pretty pessimistic at this point and hoping im wrong. If it smells like a duck, quacks like a duck, its probably a duck. Holding on to my shares as the CD10 data was good IMO and i like their prospects with HIV, cancer.....but im concerned. I think tbey should have stuck with the DSMC recommendation to evaluate at day 42. Im hopeful they have the data for both placebo and the leronlimab arm at day 42.....so even if they missed at day 28 hopefully there is statistical significance at day 42
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News